The effect of statin therapy in stroke outcome: A double blind clinical trial
Background: Through a clinical trial we evaluated statin therapy benefits over stroke outcome. Methods: All patients with moderate stroke in Middle Cerebral Artery (MCA) were registered during February 2006 to February 2008, in Al Zahra Hospital, Isfahan, Iran. Among 55 patients who were enrolled i...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
| Series: | International Journal of Preventive Medicine |
| Subjects: | |
| Online Access: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2012;volume=3;issue=1;spage=68;epage=72;aulast=Zare |
| _version_ | 1819149560116674560 |
|---|---|
| author | Mohammad Zare Mohammad Saadatnia Seyed Ali Mousavi Kiandokht Keyhanian Vahid Davoudi Esmaeil Khanmohammadi |
| author_facet | Mohammad Zare Mohammad Saadatnia Seyed Ali Mousavi Kiandokht Keyhanian Vahid Davoudi Esmaeil Khanmohammadi |
| author_sort | Mohammad Zare |
| collection | DOAJ |
| description | Background: Through a clinical trial we evaluated statin therapy benefits over stroke outcome.
Methods: All patients with moderate stroke in Middle Cerebral Artery (MCA) were registered during February 2006 to February 2008, in Al Zahra Hospital, Isfahan, Iran. Among 55 patients who were enrolled in the present study, 25 subjects received 20 mg lovastatin daily, for 90 days after stroke attack (group 1) and 30 patients received no treatment (group 2). Patients were assessed at admission, 7 and 90 days after stroke. National Institutes of Health Stroke Scale (NIHSS) score was recorded in the day 1 and 7 in the hospital with a questionnaire and BARTHEL index was estimated 90 days after stroke incidence by a telephone survey or in an outpatient visit. Data were analyzed by means of c2 , ′t′ test and Independent ′t′ test.
Results: NIHSS score measured in first day immediately after stroke attack and following 7 days, did not differ significantly in two groups. Moreover, BARTHEL index recorded within 90 days was not also different comparing group 1 and 2. After 90 days, no mortality was recorded in group 2, while one patient expired in group treating with statins (P-value>0.05).
Discussion: We did not find statins administration to play any role in stroke recovery and consequent long-term prognosis. More researches with larger samples are needed to establish the possible favorable outcome of statins when administered in cerebrovascular diseases. |
| first_indexed | 2024-12-22T14:03:33Z |
| format | Article |
| id | doaj.art-868c92a2d30a45b6aae583d7cd6e174e |
| institution | Directory Open Access Journal |
| issn | 2008-7802 2008-8213 |
| language | English |
| last_indexed | 2024-12-22T14:03:33Z |
| publishDate | 2012-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | International Journal of Preventive Medicine |
| spelling | doaj.art-868c92a2d30a45b6aae583d7cd6e174e2022-12-21T18:23:21ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132012-01-01316872The effect of statin therapy in stroke outcome: A double blind clinical trialMohammad ZareMohammad SaadatniaSeyed Ali MousaviKiandokht KeyhanianVahid DavoudiEsmaeil KhanmohammadiBackground: Through a clinical trial we evaluated statin therapy benefits over stroke outcome. Methods: All patients with moderate stroke in Middle Cerebral Artery (MCA) were registered during February 2006 to February 2008, in Al Zahra Hospital, Isfahan, Iran. Among 55 patients who were enrolled in the present study, 25 subjects received 20 mg lovastatin daily, for 90 days after stroke attack (group 1) and 30 patients received no treatment (group 2). Patients were assessed at admission, 7 and 90 days after stroke. National Institutes of Health Stroke Scale (NIHSS) score was recorded in the day 1 and 7 in the hospital with a questionnaire and BARTHEL index was estimated 90 days after stroke incidence by a telephone survey or in an outpatient visit. Data were analyzed by means of c2 , ′t′ test and Independent ′t′ test. Results: NIHSS score measured in first day immediately after stroke attack and following 7 days, did not differ significantly in two groups. Moreover, BARTHEL index recorded within 90 days was not also different comparing group 1 and 2. After 90 days, no mortality was recorded in group 2, while one patient expired in group treating with statins (P-value>0.05). Discussion: We did not find statins administration to play any role in stroke recovery and consequent long-term prognosis. More researches with larger samples are needed to establish the possible favorable outcome of statins when administered in cerebrovascular diseases.http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2012;volume=3;issue=1;spage=68;epage=72;aulast=ZareIschemic strokelovastatinstroke prognosisstatins |
| spellingShingle | Mohammad Zare Mohammad Saadatnia Seyed Ali Mousavi Kiandokht Keyhanian Vahid Davoudi Esmaeil Khanmohammadi The effect of statin therapy in stroke outcome: A double blind clinical trial International Journal of Preventive Medicine Ischemic stroke lovastatin stroke prognosis statins |
| title | The effect of statin therapy in stroke outcome: A double blind clinical trial |
| title_full | The effect of statin therapy in stroke outcome: A double blind clinical trial |
| title_fullStr | The effect of statin therapy in stroke outcome: A double blind clinical trial |
| title_full_unstemmed | The effect of statin therapy in stroke outcome: A double blind clinical trial |
| title_short | The effect of statin therapy in stroke outcome: A double blind clinical trial |
| title_sort | effect of statin therapy in stroke outcome a double blind clinical trial |
| topic | Ischemic stroke lovastatin stroke prognosis statins |
| url | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2012;volume=3;issue=1;spage=68;epage=72;aulast=Zare |
| work_keys_str_mv | AT mohammadzare theeffectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT mohammadsaadatnia theeffectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT seyedalimousavi theeffectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT kiandokhtkeyhanian theeffectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT vahiddavoudi theeffectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT esmaeilkhanmohammadi theeffectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT mohammadzare effectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT mohammadsaadatnia effectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT seyedalimousavi effectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT kiandokhtkeyhanian effectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT vahiddavoudi effectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial AT esmaeilkhanmohammadi effectofstatintherapyinstrokeoutcomeadoubleblindclinicaltrial |